168 related articles for article (PubMed ID: 36925928)
1. Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma.
Lee PH; Chiang CJ; Tseng JS; Zheng ZR; Chen KC; Chu CH; Huang YH; Hsu KH; Lee WC; Yang TY; Liu TW; Hsia JY; Chang GC
Front Oncol; 2023; 13():1096683. PubMed ID: 36925928
[TBL] [Abstract][Full Text] [Related]
2. Impact of adjuvant chemotherapy on patients with stage IB non-small cell lung cancer with visceral pleural invasion.
Kim BG; Choi J; Lee SK; Choi SI; Park CK; Sim JK; Lee H; Kim SH; Sohn JW; Yoon HJ; Lee SY; Park DW
J Thorac Dis; 2024 Feb; 16(2):875-883. PubMed ID: 38505035
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy for visceral pleural invasion in 3-4-cm non-small-cell lung cancer improves survival.
Wightman SC; Lee JY; Ding L; Atay SM; Shemanski KA; McFadden PM; David EA; Kim AW
Eur J Cardiothorac Surg; 2022 Jun; 62(1):. PubMed ID: 35325098
[TBL] [Abstract][Full Text] [Related]
4. Should patients with stage IB non-small cell lung cancer receive adjuvant chemotherapy? A comparison of survival between the 8th and 7th editions of the AJCC TNM staging system for stage IB patients.
Wang J; Wu N; Lv C; Yan S; Yang Y
J Cancer Res Clin Oncol; 2019 Feb; 145(2):463-469. PubMed ID: 30474757
[TBL] [Abstract][Full Text] [Related]
5. Influence of adjuvant chemotherapy on survival for patients with stage IB and IIA non-small cell lung cancer.
Zhang P; Duan J; Bai H; Wang Z; Gao S; Tan F; Gao Y; Wang X; Wan R; Xu J; He X; Feng X; Yu R; Sun J; Zhao Z; Fei K; Li N; He J; Wang J
Thorac Cancer; 2021 Jan; 12(1):30-39. PubMed ID: 33111432
[TBL] [Abstract][Full Text] [Related]
6. Effects of adjuvant chemotherapy on survival of patients with stage IB non-small cell lung cancer with visceral pleural invasion.
Xie J; Zhang X; Hu S; Peng WD; Xu B; Li Y; Zhang SJ; Li Q; Li C
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2231-2239. PubMed ID: 32533405
[TBL] [Abstract][Full Text] [Related]
7. Visceral pleural invasion does not affect recurrence or overall survival among patients with lung adenocarcinoma ≤ 2 cm: a proposal to reclassify T1 lung adenocarcinoma.
Nitadori JI; Colovos C; Kadota K; Sima CS; Sarkaria IS; Rizk NP; Rusch VW; Travis WD; Adusumilli PS
Chest; 2013 Nov; 144(5):1622-1631. PubMed ID: 23807749
[TBL] [Abstract][Full Text] [Related]
8. Effect of Adjuvant Chemotherapy on Survival of Patients With 8th Edition Stage IB Non-Small Cell Lung Cancer.
Xu Y; Wan B; Zhu S; Zhang T; Xie J; Liu H; Zhan P; Lv T; Song Y
Front Oncol; 2021; 11():784289. PubMed ID: 35155190
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of adjuvant chemotherapy for completely resected stage IB non-small cell lung cancer: a retrospective study.
Park HJ; Park HS; Cha YJ; Lee S; Jeung HC; Cho JY; Kim HJ; Byun MK
J Thorac Dis; 2018 Apr; 10(4):2279-2287. PubMed ID: 29850132
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of platinum-based adjuvant chemotherapy in T2aN0 stage IB non-small cell lung cancer.
Park SY; Lee JG; Kim J; Byun GE; Bae MK; Lee CY; Kim DJ; Chung KY
J Cardiothorac Surg; 2013 Jun; 8():151. PubMed ID: 23759129
[TBL] [Abstract][Full Text] [Related]
11. Association of Survival With Adjuvant Chemotherapy Among Patients With Early-Stage Non-Small Cell Lung Cancer With vs Without High-Risk Clinicopathologic Features.
Pathak R; Goldberg SB; Canavan M; Herrin J; Hoag JR; Salazar MC; Papageorge M; Ermer T; Boffa DJ
JAMA Oncol; 2020 Nov; 6(11):1741-1750. PubMed ID: 32940636
[TBL] [Abstract][Full Text] [Related]
12. Treatment Modality for Stage IB Peripheral Non-Small Cell Lung Cancer With Visceral Pleural Invasion and ≤3 cm in Size.
Huang W; Deng HY; Lin MY; Xu K; Zhang YX; Yuan C; Zhou Q
Front Oncol; 2022; 12():830470. PubMed ID: 35280762
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of adjuvant chemotherapy versus surgery alone in T2aN0 stage IB non-small cell lung cancer.
Zhang T; Guo Q; Zhang Y; Liu Z; Zhou S; Xu S
J Cancer Res Ther; 2018 Jan; 14(1):139-144. PubMed ID: 29516976
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemotherapy may improve long-term outcomes in stage IB non-small cell lung cancer patients with previous malignancies: A propensity score-matched analysis.
Zhou K; Zhao Y; Liang L; Cao J; Lin H; Peng Z; Mei J
Front Oncol; 2022; 12():938195. PubMed ID: 36119504
[TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy of adjuvant chemotherapy in stage IB (< 4 cm) non-small cell lung cancer patients with high-risk factors.
Choi J; Oh JY; Lee YS; Min KH; Shim JJ; Choi SI; Park DW; Park CK; Kang EJ; Yong HS; Shin BK; Kim HK; Lee SY
Korean J Intern Med; 2022 Jan; 37(1):127-136. PubMed ID: 32872735
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Impact of Multiple Clinicopathologic Risk Factors and c-MET Overexpression in Patients Who Have Undergone Resection of Stage IB Non-Small-Cell Lung Cancer.
Kim IH; Lee IH; Lee JE; Hong SH; Kim TJ; Lee KY; Kim YK; Kim SJ; Sung SW; Park JK; Yoo IR; Kim YS; Kim JO; Kang JH
Clin Lung Cancer; 2016 Sep; 17(5):e31-e43. PubMed ID: 26992846
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Factors for Survival of Stage IB Non-small Cell Lung Cancer Patients: A 10-Year Follow-Up Retrospective Study.
Yang Z; Li X; Bai J; Li D; Ma Z; Deng C; Fu F; Zhang Y
Ann Surg Oncol; 2023 Nov; 30(12):7481-7491. PubMed ID: 37535274
[TBL] [Abstract][Full Text] [Related]
18. Re-evaluation of the prognostic value of visceral pleura invasion in Stage IB non-small cell lung cancer using the prospective multicenter ACOSOG Z0030 trial data set.
Fibla JJ; Cassivi SD; Brunelli A; Decker PA; Allen MS; Darling GE; Landreneau RJ; Putnam JB
Lung Cancer; 2012 Dec; 78(3):259-62. PubMed ID: 23040416
[TBL] [Abstract][Full Text] [Related]
19. Impact of surgery and adjuvant chemotherapy on the survival of stage I lung adenocarcinoma patients with tumor spread through air spaces.
Lv Y; Li S; Liu Z; Ren Z; Zhao J; Tao G; Zheng Z; Han Y; Ye B
Lung Cancer; 2023 Mar; 177():51-58. PubMed ID: 36736075
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma.
Qian F; Yang W; Wang R; Xu J; Wang S; Zhang Y; Jin B; Yu K; Han B
J Thorac Cardiovasc Surg; 2018 Mar; 155(3):1227-1235.e2. PubMed ID: 29223834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
